Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Proteomic data on the nuclear interactome of human MCM9.

Hutchins JR, Traver S, Coulombe P, Peiffer I, Kitzmann M, Latreille D, Méchali M.

Data Brief. 2015 Dec 11;6:410-5. doi: 10.1016/j.dib.2015.11.055. eCollection 2016 Mar.

2.

MCM9 Is Required for Mammalian DNA Mismatch Repair.

Traver S, Coulombe P, Peiffer I, Hutchins JR, Kitzmann M, Latreille D, Méchali M.

Mol Cell. 2015 Sep 3;59(5):831-9. doi: 10.1016/j.molcel.2015.07.010. Epub 2015 Aug 20.

3.

Defects in TLR3 expression and RNase L activation lead to decreased MnSOD expression and insulin resistance in muscle cells of obese people.

Fabre O, Breuker C, Amouzou C, Salehzada T, Kitzmann M, Mercier J, Bisbal C.

Cell Death Dis. 2014 Mar 20;5:e1136. doi: 10.1038/cddis.2014.104.

4.

Increased FAT/CD36 cycling and lipid accumulation in myotubes derived from obese type 2 diabetic patients.

Aguer C, Foretz M, Lantier L, Hebrard S, Viollet B, Mercier J, Kitzmann M.

PLoS One. 2011;6(12):e28981. doi: 10.1371/journal.pone.0028981. Epub 2011 Dec 16.

5.

Abnormal metabolism flexibility in response to high palmitate concentrations in myotubes derived from obese type 2 diabetic patients.

Kitzmann M, Lantier L, Hébrard S, Mercier J, Foretz M, Aguer C.

Biochim Biophys Acta. 2011 Apr;1812(4):423-30. doi: 10.1016/j.bbadis.2010.12.007. Epub 2010 Dec 21.

6.

Intramyocellular lipid accumulation is associated with permanent relocation ex vivo and in vitro of fatty acid translocase (FAT)/CD36 in obese patients.

Aguer C, Mercier J, Man CY, Metz L, Bordenave S, Lambert K, Jean E, Lantier L, Bounoua L, Brun JF, Raynaud de Mauverger E, Andreelli F, Foretz M, Kitzmann M.

Diabetologia. 2010 Jun;53(6):1151-63. doi: 10.1007/s00125-010-1708-x. Epub 2010 Mar 25.

PMID:
20333349
7.

Lipid content and response to insulin are not invariably linked in human muscle cells.

Aguer C, Mercier J, Kitzmann M.

Mol Cell Endocrinol. 2010 Feb 5;315(1-2):225-32. doi: 10.1016/j.mce.2009.10.017. Epub 2009 Nov 6.

PMID:
19897010
8.

[Physical exercise and insulin resistance: from muscle metabolic physiopathology to therapeutics].

Bordenave S, Aguer C, Kitzmann M, Mercier J.

J Soc Biol. 2007;201(2):149-54. French.

PMID:
17978747
9.

Inhibition of Notch signaling induces myotube hypertrophy by recruiting a subpopulation of reserve cells.

Kitzmann M, Bonnieu A, Duret C, Vernus B, Barro M, Laoudj-Chenivesse D, Verdi JM, Carnac G.

J Cell Physiol. 2006 Sep;208(3):538-48.

PMID:
16741964
10.

Intracellular retention of caveolin 1 in presenilin-deficient cells.

Wood DR, Nye JS, Lamb NJ, Fernandez A, Kitzmann M.

J Biol Chem. 2005 Feb 25;280(8):6663-8. Epub 2004 Dec 21.

11.

Transient induction of cyclin A in loaded chicken skeletal muscle.

Flück M, Kitzmann M, Däpp C, Chiquet M, Booth FW, Fernandez A.

J Appl Physiol (1985). 2003 Oct;95(4):1664-71. Epub 2003 Jun 20.

12.

Identification and characterization of presenilin-independent Notch signaling.

Berechid BE, Kitzmann M, Foltz DR, Roach AH, Seiffert D, Thompson LA, Olson RE, Bernstein A, Donoviel DB, Nye JS.

J Biol Chem. 2002 Mar 8;277(10):8154-65. Epub 2001 Dec 26.

13.

Crosstalk between cell cycle regulators and the myogenic factor MyoD in skeletal myoblasts.

Kitzmann M, Fernandez A.

Cell Mol Life Sci. 2001 Apr;58(4):571-9. Review.

PMID:
11361092
14.

Cyclin E-cdk2 phosphorylation promotes late G1-phase degradation of MyoD in muscle cells.

Tintignac LA, Leibovitch MP, Kitzmann M, Fernandez A, Ducommun B, Meijer L, Leibovitch SA.

Exp Cell Res. 2000 Aug 25;259(1):300-7.

PMID:
10942602
15.

Modulation of L-type calcium channel expression during retinoic acid-induced differentiation of H9C2 cardiac cells.

Ménard C, Pupier S, Mornet D, Kitzmann M, Nargeot J, Lory P.

J Biol Chem. 1999 Oct 8;274(41):29063-70.

16.

cdk1- and cdk2-mediated phosphorylation of MyoD Ser200 in growing C2 myoblasts: role in modulating MyoD half-life and myogenic activity.

Kitzmann M, Vandromme M, Schaeffer V, Carnac G, Labbé JC, Lamb N, Fernandez A.

Mol Cell Biol. 1999 Apr;19(4):3167-76.

17.

The muscle regulatory factors MyoD and myf-5 undergo distinct cell cycle-specific expression in muscle cells.

Kitzmann M, Carnac G, Vandromme M, Primig M, Lamb NJ, Fernandez A.

J Cell Biol. 1998 Sep 21;142(6):1447-59.

18.

Retinoic acid receptors and muscle b-HLH proteins: partners in retinoid-induced myogenesis.

Froeschlé A, Alric S, Kitzmann M, Carnac G, Auradé F, Rochette-Egly C, Bonnieu A.

Oncogene. 1998 Jul 2;16(26):3369-78. Erratum in: Oncogene 1998 Dec 10;17(23):3071.

19.

RhoA GTPase and serum response factor control selectively the expression of MyoD without affecting Myf5 in mouse myoblasts.

Carnac G, Primig M, Kitzmann M, Chafey P, Tuil D, Lamb N, Fernandez A.

Mol Biol Cell. 1998 Jul;9(7):1891-902.

20.

Cyclin dependent kinase 5, cdk5, is a positive regulator of myogenesis in mouse C2 cells.

Lazaro JB, Kitzmann M, Poul MA, Vandromme M, Lamb NJ, Fernandez A.

J Cell Sci. 1997 May;110 ( Pt 10):1251-60.

21.

cdk5 expression and association with p35nck5a in early stages of rat cerebellum neurogenesis; tyrosine dephosphorylation and activation in post-mitotic neurons.

Lazaro JB, Kitzmann M, Cavadore JC, Muller Y, Clos J, Fernandez A, Lamb NJ.

Neurosci Lett. 1996 Oct 25;218(1):21-4.

PMID:
8939471

Supplemental Content

Loading ...
Support Center